INTRODUCTION: Androgens regulate a wide array of physiological processes, including male sexual development, bone and muscle growth, and behavior and cognition. Because androgens play a vital role in so many tissues, changes in androgen signaling are associated with a plethora of diseases. How such varied responses are achieved by a single stimulus is not well understood. Androgens act primarily through the androgen receptor (AR), a hormone nuclear receptor that is expressed in a select variety of tissues. METHODS: In order to gain a better understanding of how the tissue-selective effects of androgens are achieved, we performed a comparison of microarray data, using previously published datasets and several of our own microarray datasets. These datasets were derived from clinically relevant, AR-expressing tissues dissected from rodents treated with the full androgen dihydrotestosterone (DHT). RESULTS: We found that there is a diverse response to DHT, with very little overlap of androgen regulated genes in each tissue. Gene ontology analyses also indicated that, while several tissues regulate similar biological processes in response to DHT, most androgen regulated processes are specific to one or a few tissues. Thus, it appears that the disparate physiological effects mediated by androgens begin with widely varying effects on gene expression in different androgen-sensitive tissues. CONCLUSION: The analysis completed in this study will lead to an improved understanding of how androgens mediate diverse, tissue-specific processes and better ways to assess the tissue-selective effects of AR modulators during drug development.
INTRODUCTION: Androgens regulate a wide array of physiological processes, including male sexual development, bone and muscle growth, and behavior and cognition. Because androgens play a vital role in so many tissues, changes in androgen signaling are associated with a plethora of diseases. How such varied responses are achieved by a single stimulus is not well understood. Androgens act primarily through the androgen receptor (AR), a hormone nuclear receptor that is expressed in a select variety of tissues. METHODS: In order to gain a better understanding of how the tissue-selective effects of androgens are achieved, we performed a comparison of microarray data, using previously published datasets and several of our own microarray datasets. These datasets were derived from clinically relevant, AR-expressing tissues dissected from rodents treated with the full androgen dihydrotestosterone (DHT). RESULTS: We found that there is a diverse response to DHT, with very little overlap of androgen regulated genes in each tissue. Gene ontology analyses also indicated that, while several tissues regulate similar biological processes in response to DHT, most androgen regulated processes are specific to one or a few tissues. Thus, it appears that the disparate physiological effects mediated by androgens begin with widely varying effects on gene expression in different androgen-sensitive tissues. CONCLUSION: The analysis completed in this study will lead to an improved understanding of how androgens mediate diverse, tissue-specific processes and better ways to assess the tissue-selective effects of AR modulators during drug development.
Authors: Y Klipper-Aurbach; M Wasserman; N Braunspiegel-Weintrob; D Borstein; S Peleg; S Assa; M Karp; Y Benjamini; Y Hochberg; Z Laron Journal: Med Hypotheses Date: 1995-11 Impact factor: 1.538
Authors: Nirao M Shah; David J Pisapia; Silas Maniatis; Monica M Mendelsohn; Adriana Nemes; Richard Axel Journal: Neuron Date: 2004-08-05 Impact factor: 17.173
Authors: Pascale V Nantermet; Jian Xu; Yuanjiang Yu; Paul Hodor; Daniel Holder; Sharon Adamski; Michael A Gentile; Donald B Kimmel; Shun-Ichi Harada; David Gerhold; Leonard P Freedman; William J Ray Journal: J Biol Chem Date: 2003-10-23 Impact factor: 5.157
Authors: Luis O Gonzalez; Maria D Corte; Julio Vazquez; Sara Junquera; Rosario Sanchez; Ana C Alvarez; Juan C Rodriguez; Maria L Lamelas; Francisco J Vizoso Journal: BMC Cancer Date: 2008-05-28 Impact factor: 4.430
Authors: D B Hoffmann; M Komrakova; S Pflug; M von Oertzen; D Saul; L Weiser; T A Walde; M Wassmann; A F Schilling; W Lehmann; S Sehmisch Journal: J Bone Miner Metab Date: 2018-05-21 Impact factor: 2.626
Authors: Shehzad Basaria; Ravi Jasuja; Grace Huang; Whitney Wharton; Hong Pan; Karol Pencina; Zhuoying Li; Thomas G Travison; Jag Bhawan; Renaud Gonthier; Fernand Labrie; Alain Y Dury; Carlo Serra; Allen Papazian; Michael O'Leary; Sami Amr; Thomas W Storer; Emily Stern; Shalender Bhasin Journal: J Clin Endocrinol Metab Date: 2016-09-23 Impact factor: 5.958
Authors: Leon E Gray; Johnathan R Furr; Christy S Lambright; Nicola Evans; Phillip C Hartig; Mary C Cardon; Vickie S Wilson; Andrew K Hotchkiss; Justin M Conley Journal: Toxicol Sci Date: 2020-08-01 Impact factor: 4.109
Authors: Ben Yi Tew; Teresa B Hong; Maya Otto-Duessel; Catherine Elix; Egbert Castro; Miaoling He; Xiwei Wu; Sumanta K Pal; Markus Kalkum; Jeremy O Jones Journal: Oncotarget Date: 2017-02-21